Evaluating the Efficacy and Feasibility of a Novel Wireless ECG Recording System in Monitoring Patients After Atrial Fibrillation Ablation Procedure

Completed

Conditions studied: Persistent Atrial Fibrillation, Paroxysmal Atrial Fibrillation

In brief

The investigators goal in this study is to examine the feasibility and efficacy of AliveCor iphone case monitoring device in monitoring patients after AF ablation by comparing transmissions using Alive Cor with transmissions from a traditional transtelephonic monitor (TTM). A secondary goal is to assess the ease of use of AliveCor device compared to traditional TTM system from the patient's perspective

Key facts

Study ID

NCT01912911

Run by

The Cleveland Clinic

People needed

60

Starts

2013-06-01

Expected to finish

2014-06-01

Last updated by the study team

2014-08-07

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female between > 18 and < 75 years of age
• Paroxysmal or persistent atrial fibrillation
• Scheduled to undergo an AF ablation procedure
• Already has iPhone 4 or iPhone 4S with data plan
• Willing to use the iPhone Alive Cor case
• Written informed consent

You may not qualify if…

• Unable or unwilling to use the Alive Cor case for their iPhone or iPhone 4S
• Residing outside the United States

Where it is running

• Cleveland Clinic HVI — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.